Emergent BioSolutions Inc.
(NYSE:EBS)|
22.37 -0.25 (-1.10%) Dec 01 - Close |
|
|
|
After-Hours 22.95 +0.58 (2.59%) Mon, 1 Dec 2008 6:50 PM
- Compare EBS with:
- View: Line | Candlestick
Company Profile
Emergent BioSolutions Inc.
2273 Research Boulevard
Rockville, MD 20850
United States - Map
Phone: (301) 795-1800
Fax: (301) 795-1899
Website: www.emergentbiosolutions.com
State of incorporation: Delaware
CEO: Fuad El-Hibri
Employees: 560
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
A Biopharma co. focused on immunobiotics.
A multinational biopharmaceutical company, which focuses on the development, manufacture and commercialization of immunobiotics, consisting of vaccines and therapeutics that assist the body's immune system to prevent or treat disease.
Recent news for EBS
-
Emergent BioSolutions Looking Strong, Even on a Bad Day
Seeking Alpha - 10 hours ago
-
Company Answers Call For Anthrax Vaccine
Investor's Business Daily - Nov 28 at 5:05 ET
-
A Giving Strategy for Penny Pinchers
Motley Fool - Nov 28 at 10:19 ET
-
New Emerging Biotech and Pharma Company Index
Seeking Alpha - Nov 23 at 10:14 ET
-
EMERGENT BIOSOLUTIONS INC. Financials
EDGAR Online Financials - Nov 22 at 9:04 ET
-
Emergent BioSolutions Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha - Nov 21 at 3:39 ET
-
You Can't Resist This Stock Price
Motley Fool - Nov 20 at 4:09 ET
-
The Guru's Corner: Five snapback candidates for a market turnaround
MarketWatch - Nov 20 at 1:20 ET
-
Business Wire - Nov 18 at 4:44 ET
-
Emergent BioSolutions Files Shelf Registration
Seeking Alpha - Nov 13 at 6:16 ET
Top members owning EBS
-
Top 60%
-40.84%3m:
-40.80%YTD:
-
Top 1%
18.38%3m:
18.38%YTD: